Fig. 1
From: Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
Overview of study organisation. iBEAt study organigram showing central roles (grey ellipse) and recruiting sites with ancillary studies (circles). BMs = biomarkers; QA = quality assurance; RBF = renal blood flow; PET = Positron-emission tomography; SIB = Swiss Institute of Bioinformatics; T1D = type 1 diabetes; Umich = University of Michigan